APLM
Price
$8.22
Change
+$0.72 (+9.60%)
Updated
Dec 18, 04:59 PM (EDT)
FATE
Price
$1.68
Change
-$0.20 (-10.64%)
Updated
Dec 18, 04:59 PM (EDT)
75 days until earnings call
Ad is loading...

APLM vs FATE

Header iconAPLM vs FATE Comparison
Open Charts APLM vs FATEBanner chart's image
Apollomics
Price$8.22
Change+$0.72 (+9.60%)
Volume$558
CapitalizationN/A
Fate Therapeutics
Price$1.68
Change-$0.20 (-10.64%)
Volume$15.94K
CapitalizationN/A
APLM vs FATE Comparison Chart
Loading...
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLM vs. FATE commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and FATE is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (APLM: $7.50 vs. FATE: $1.88)
Brand notoriety: APLM and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 42% vs. FATE: 94%
Market capitalization -- APLM: $8.27M vs. FATE: $214.12M
APLM [@Biotechnology] is valued at $8.27M. FATE’s [@Biotechnology] market capitalization is $214.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 1 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • APLM’s FA Score: 1 green, 4 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, both APLM and FATE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 2 TA indicator(s) are bullish while FATE’s TA Score has 3 bullish TA indicator(s).

  • APLM’s TA Score: 2 bullish, 7 bearish.
  • FATE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, FATE is a better buy in the short-term than APLM.

Price Growth

APLM (@Biotechnology) experienced а +4.75% price change this week, while FATE (@Biotechnology) price change was -17.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

APLM is expected to report earnings on Mar 31, 2023.

FATE is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($214M) has a higher market cap than APLM($8.27M). FATE YTD gains are higher at: -49.733 vs. APLM (-92.228).
APLMFATEAPLM / FATE
Capitalization8.27M214M4%
EBITDAN/AN/A-
Gain YTD-92.228-49.733185%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt4.72MN/A-
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLMFATE
RSI
ODDS (%)
Bearish Trend 2 days ago
38%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
37%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
38%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APLM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with HCWB. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then HCWB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
-8.87%
HCWB - APLM
55%
Loosely correlated
-6.94%
RVMD - APLM
33%
Poorly correlated
+1.01%
FATE - APLM
28%
Poorly correlated
-6.00%
ARTL - APLM
27%
Poorly correlated
-3.77%
BVAXF - APLM
27%
Poorly correlated
+21.03%
More

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-6.00%
ALLO - FATE
58%
Loosely correlated
+0.49%
RCKT - FATE
52%
Loosely correlated
+1.36%
NTLA - FATE
51%
Loosely correlated
-1.87%
CRBU - FATE
50%
Loosely correlated
+1.57%
BEAM - FATE
50%
Loosely correlated
-1.21%
More